Cargando…

Influence of Selective Dopamine Agonist Ropinirole on Conditioned Place Preference and Somatic Signs of Morphine Withdrawal in Rats

The underlying mechanism of dependence and rewarding effects of morphine is imperative to understand. The primary aim of this study was to investigate whether ropinirole D2/3 agonist affects the rewarding and reinforcing properties of morphine-induced conditioned place preference (CPP) and withdrawa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahzadi, Andleeb, Yunusoglu, Oruc, Karabulut, Enes, Sonmez, Haktan, Yazici, Zeliha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207507/ https://www.ncbi.nlm.nih.gov/pubmed/35733518 http://dx.doi.org/10.3389/fnbeh.2022.855241

Ejemplares similares

Effect of sulfasalazine on endothelium-dependent vascular response by the activation of Nrf2 signalling pathway
por: Sonmez, Muhammed Ikbal, et al.
Publicado: (2022)

Comparison of long‐term use of prolonged‐release ropinirole and immediate‐release dopamine agonists in an observational study in patients with Parkinson's disease
por: Gungabissoon, Usha, et al.
Publicado: (2020)

Evaluation of demographic characteristics, and general disease state of patients affliated with home health care unit of Malatya State Hospital
por: Oksuz, Ersoy, et al.
Publicado: (2015)

The Prevalence of Potential Drug-Drug Interactions in CKD-A Retrospective Observational Study of Cerrahpasa Nephrology Unit
por: Shahzadi, Andleeb, et al.
Publicado: (2022)

Oleanolic Acid Attenuates Morphine Withdrawal Symptoms in Rodents: Association with Regulation of Dopamine Function
por: Shi, Zhiqi, et al.
Publicado: (2021)

Ropinirole, a dopamine agonist with high D(3) affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adults
por: Rawji, Vishal, et al.
Publicado: (2020)

Causes and factors related to dopamine agonist withdrawal in Parkinson′s disease
por: Castro, Ester Suárez, et al.
Publicado: (2016)

Irreversible extreme freezing of gait after dopamine agonist withdrawal
por: Salari, Mehri, et al.
Publicado: (2021)

Ropinirole for the treatment of restless legs syndrome
por: Kushida, Clete A
Publicado: (2006)

Update on ropinirole in the treatment of Parkinson’s disease
por: Shill, Holly A, et al.
Publicado: (2009)

Spectrophotometric Estimation of Ropinirole Hydrochloride in Tablets
por: Shete, Yogita, et al.
Publicado: (2009)

Treatment of Gait Ignition Failure with Ropinirole
por: Cohen-Oram, Alexis N., et al.
Publicado: (2014)

Potential effect of luteolin, epiafzelechin, and albigenin on rats under cadmium-induced inflammatory insult: In silico and in vivo approach
por: Shahzadi, Andleeb, et al.
Publicado: (2023)

The gut microbiome contributes to somatic morphine withdrawal behavior and implicates a TLR2 mediated mechanism
por: Truitt, Bridget, et al.
Publicado: (2023)

Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review
por: Garcia, Xiomara, et al.
Publicado: (2022)

Alteration of neuroinflammation detected by (18)F-GE180 PET imaging in place-conditioned rats with morphine withdrawal
por: Li, Junpeng, et al.
Publicado: (2021)

Alleviation of Morphine Withdrawal Signs but Not Tolerance by the Essential Oil of Kelussia odoratissima Mozaff.
por: Rabbani, Mohammed, et al.
Publicado: (2012)

Thymus Daenensis Extract and Essential Oils Effects on Morphine Withdrawal Signs in Mice
por: Khodayar, Mohammad Javad, et al.
Publicado: (2014)

The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis
por: Zou, Yunzhi, et al.
Publicado: (2021)

First electrochemical evaluation of favipiravir used as an antiviral option in the treatment of COVID-19: A study of its enhanced voltammetric determination in cationic surfactant media using a boron-doped diamond electrode()
por: Allahverdiyeva, Shabnam, et al.
Publicado: (2021)

A review of ropinirole prolonged release in Parkinson’s disease
por: Nashatizadeh, Muhammad M, et al.
Publicado: (2009)

Othello Syndrome Secondary to Ropinirole: A Case Study
por: Pal, Kakali, et al.
Publicado: (2012)

Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease
por: Barcia, Emilia, et al.
Publicado: (2017)

Clinical Observation of Ropinirole Hydrochloride in the Treatment of Parkinson's Disease
por: Zhang, JingZhou, et al.
Publicado: (2022)

Metabolism of ropinirole is mediated by several canine CYP enzymes
por: Tervahauta, Tuomas, et al.
Publicado: (2023)

Geraniin attenuates naloxone-precipitated morphine withdrawal and morphine-induced tolerance in mice
por: Kasanga, Ella Anle, et al.
Publicado: (2017)

Morphine Withdrawal Enhances HIV Infection of Macrophages
por: Wang, Xu, et al.
Publicado: (2019)

Attenuation of Withdrawal Signs, Blood Cortisol, and Glucose Level with Various Dosage Regimens of Morphine after Precipitated Withdrawal Syndrome in Mice
por: Motaghinejad, Majid, et al.
Publicado: (2016)

Involvement of Basolateral Amygdala Dopamine D1 Receptors in the Acquisition and Expression of Morphine-Induced Place Preference in Rats
por: Rezaei, Zahra, et al.
Publicado: (2022)

Morphine Withdrawal-Induced Hyperalgesia in Models of Acute and Extended Withdrawal Is Attenuated by l-Tetrahydropalmatine
por: Oleinichenko, Daria, et al.
Publicado: (2023)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Ropinirole in restless legs syndrome and periodic limb movement disorder
por: Erichsen, Daniel, et al.
Publicado: (2010)

Sleepiness and Depression in Parkinson’s Disease Patients Treated with Ropinirole and Levodopa
por: Kang, Suk Yun, et al.
Publicado: (2017)

Retracted: Clinical Observation of Ropinirole Hydrochloride in the Treatment of Parkinson's Disease
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Mitragynine Attenuates Withdrawal Syndrome in Morphine-Withdrawn Zebrafish
por: Khor, Beng-Siang, et al.
Publicado: (2011)

Effect of Potassium Channel Modulators on Morphine Withdrawal in Mice
por: Seth, Vikas, et al.
Publicado: (2010)

An Engineered Endomorphin-2 Gene for Morphine Withdrawal Syndrome
por: Wu, Fei-xiang, et al.
Publicado: (2016)

A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal
por: Chisamore, Brian, et al.
Publicado: (2016)

Microinjection of a Dopamine-D1 Receptor Agonist into the Ventral Tegmental Area Reverses the Blocked Expression of Morphine Conditioned Place Preference by N-Methyl-D-Aspartate Receptor Antagonist
por: Ahmadian, Seyed Mostafa, et al.
Publicado: (2020)

Attenuation of morphine withdrawal signs, blood cortisol and glucose level with forced exercise in comparison with clonidine
por: Motaghinejad, Majid, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tk38dpjgmgaplktnm7q8qb0lm5